Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
75
CADL Quote, Financials, Valuation and Earnings
Last price:
$6.07
Seasonality move
:
2.55%
Day range:
$5.86 - $6.14
52-week range:
$4.25 - $13.68
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1,949.18x
P/B ratio:
4.17x
Volume:
345.9K
Avg. volume:
929.3K
1-year change:
-30.91%
Market cap:
$333.8M
Revenue:
--
EPS (TTM):
-$0.56
Earnings Data
Next earnings date for CADL
Mar 12
2026
Most recent earnings per share
-$0.21
Missed by $0.04
(Nov 13/2025)
Consensus Estimate
-$0.17
(Nov 13/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CADL Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/12/2026 | Q4 | -- | -- | -- | -$0.24 | -- |
| 11/13/2025 | Q3 | -- | -- | -$0.21 | -$0.17 | -$0.04 |
| 08/14/2025 | Q2 | -- | -- | -$0.09 | -$0.18 | $0.08 |
| 05/15/2025 | Q1 | -- | -- | $0.13 | -$0.24 | $0.37 |
| 03/13/2025 | Q4 | -- | -- | -$0.40 | -$0.23 | -$0.17 |
| 11/14/2024 | Q3 | -- | -- | -$0.33 | -- | -- |
| 08/13/2024 | Q2 | -- | -- | -$0.74 | -- | -- |
| 05/14/2024 | Q1 | -- | -- | -$0.28 | -- | -- |
| 03/28/2024 | Q4 | -- | -- | -$0.38 | -- | -- |
| 11/09/2023 | Q3 | -- | -- | -$0.29 | -- | -- |
| 08/10/2023 | Q2 | -- | -- | -$0.33 | -$0.37 | $0.04 |
| 05/11/2023 | Q1 | -- | -- | -$0.30 | -- | -- |
| 03/30/2023 | Q4 | -- | $31K | -$0.18 | -- | -- |
| 11/10/2022 | Q3 | -- | $31K | -$0.30 | -- | -- |
| 08/05/2022 | Q2 | -- | $31K | -$0.14 | -- | -- |
| 05/12/2022 | Q1 | -- | $31K | -$0.03 | -- | -- |
| 03/29/2022 | Q4 | -- | $31K | $0.05 | -- | -- |
| 11/12/2021 | Q3 | -- | $31K | -$0.56 | -- | -- |
| 09/08/2021 | Q2 | -- | $31K | -$0.60 | -- | -- |
| 03/31/2021 | Q1 | -- | $31K | -$0.15 | -- | -- |
| 12/31/2020 | Q4 | -- | $31K | -$0.56 | -- | -- |
| 09/30/2020 | Q3 | -- | $31K | -$0.09 | -- | -- |
| 06/30/2020 | Q2 | -- | $31K | -$0.15 | -- | -- |
| 03/31/2020 | Q1 | -- | $31K | -$0.06 | -- | -- |
Candel Therapeutics, Inc. Earnings Questions
-
How Much did Candel Therapeutics, Inc. Generate in Revenue Last Quarter?
Candel Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Candel Therapeutics, Inc. Beat Earnings Last Quarter?
Candel Therapeutics, Inc. announced earnings per share of -$0.21 which represents a miss of analyst forecast a -$0.17 per share.
-
Is Candel Therapeutics, Inc. Profitable?
Candel Therapeutics, Inc. reported -$195K that represents -$0.00 per share over the last quarter.
-
What is the Analyst Consensus for Candel Therapeutics, Inc. EPS Next Year?
Candel Therapeutics, Inc.'s earnings are forecast to decrease from -$1.74 per share to -$1.14 per share next year representing a decrease of -65.27%.
-
When is Candel Therapeutics, Inc.'s Earnings Date?
Candel Therapeutics, Inc.'s next earnings date is March 12, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
